Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma™ - continuous high-shear granulation and drying lines.

The ConsiGma™ high-shear granulation and drying concept is capable of producing pharmaceutical granules continuously, without start-up and shut-down waste. This concept enables the use of the same system for development and production work without the need for scale-up, as the determining factor for batch size is not the volume of the process vessel, but the running time. Scale-up has always been a very risky, time-consuming and costly exercise in tablet development and manufacturing. From now on, we can change the batch size without touching the process conditions.